To fill this clinical gap, we conducted an evaluation of the role of APOE ε2 in longitudinal cognitive function among older breast cancer survivors and a matched noncancer control group in the Thinking and Living with Cancer (TLC) study (15,20). The gene discussed is APOE; the disease is breast cancer.